Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Antwerp
With
Merck Sharp & Dohme LLC
Aerocrine AB
Age
5–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female children, aged 6-14 years
A documented history of asthma for a period of at least 6 months
Mild to severe persistent asthma according to GINA guidelines
A documented history of allergic sensitization (positive skin prick test or specific IgE
Subject's guardian/parent should be able to complete a symptom score on behalf of the subject.
Subject's guardian/parent should be able to send a symptom score weekly by sms
Both parents have to give written informed consent to participate in the study
You may not be if
Received any investigational study medication in the 4 weeks prior to screening Visit
Significant comorbidity such as concurrent infection, history of prematurity, history of bronchopulmonary dysplasia, cystic fibrosis, other chronic lung diseases, and other severe chronic diseases
Acute asthma exacerbation within 4 weeks of screening visit
Hospitalization within 12 weeks of screening visit
Systemic corticosteroids within 12 weeks of screening visit
Oral corticosteroid dependence
Clareo Health | Monitoring Asthma Treatment Using Exhaled Nitric Oxide
